CHLORHEXIDINE GLUCONATE

CHLORHEXIDINE GLUCONATE was reported 9353 times

CHLORHEXIDINE GLUCONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BURKHOLDERIA CEPACIA INFECTION 22 0.6286
1 HEPATIC ENZYME 81 0.5436
2 FACET JOINT SYNDROME 792 0.2430
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 462 0.2307
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 150 0.2246
5 SWOLLEN JOINT COUNT 52 0.2080
6 C-REACTIVE PROTEIN 188 0.2028
7 GRIP STRENGTH 45 0.1965
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 400 0.1929
9 DUODENAL ULCER PERFORATION 1390 0.1867
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1287 0.1794
11 DISLOCATION OF VERTEBRA 406 0.1778
12 X-RAY ABNORMAL 315 0.1760
13 RHEUMATIC FEVER 759 0.1701
14 MUSCLE INJURY 1387 0.1672
15 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 89 0.1586
16 FOLLICULITIS 1663 0.1584
17 MECHANICAL VENTILATION COMPLICATION 23 0.1544
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 994 0.1529
19 SWOLLEN JOINT COUNT INCREASED 486 0.1523
20 PERIPHERAL VENOUS DISEASE 611 0.1495
21 HELICOBACTER INFECTION 1489 0.1447
22 LUPUS VULGARIS 182 0.1444
23 HYPOCHOLESTEROLAEMIA 42 0.1190
24 ANGIOKERATOMA 10 0.1176
25 HAND DEFORMITY 1534 0.1168
26 PEMPHIGUS 1392 0.1112
27 BURKHOLDERIA INFECTION 9 0.1084
28 PORPHYRIA ACUTE 152 0.1059
29 C-REACTIVE PROTEIN ABNORMAL 658 0.1025
30 RETINITIS 174 0.1006
31 RHEUMATOID FACTOR POSITIVE 581 0.1005
32 BREAST CANCER STAGE III 631 0.0973
33 LIP DRY 860 0.0946
34 INSPIRATORY CAPACITY DECREASED 25 0.0903
35 PERICARDITIS 1343 0.0799
36 SYNOVITIS 1385 0.0767
37 IRRITABLE BOWEL SYNDROME 1538 0.0717
38 JOINT RANGE OF MOTION DECREASED 947 0.0705
39 GLOSSODYNIA 1572 0.0701
40 BONE EROSION 242 0.0684
41 HYPERCHOLESTEROLAEMIA 658 0.0681
42 BLEPHAROSPASM 422 0.0670
43 ONYCHOMADESIS 280 0.0667
44 GRIP STRENGTH DECREASED 577 0.0655
45 BURSITIS 790 0.0650
46 WOUND INFECTION 707 0.0645
47 OSTEORADIONECROSIS 14 0.0631
48 ANTIPHOSPHOLIPID ANTIBODIES 12 0.0615
49 SERONEGATIVE ARTHRITIS 70 0.0611
50 BURKHOLDERIA CEPACIA COMPLEX INFECTION 17 0.0594
51 GINGIVAL OEDEMA 10 0.0568
52 LIVE BIRTH 469 0.0560
53 ONYCHOMYCOSIS 238 0.0542
54 FINGER DEFORMITY 262 0.0540
55 OVERLAP SYNDROME 37 0.0529
56 IMPAIRED HEALING 1710 0.0520
57 WOUND 1393 0.0498
58 NAIL DISORDER 423 0.0483
59 AUTOIMMUNE DISORDER 451 0.0462
60 PRIMARY SEQUESTRUM 41 0.0453
61 MATERNAL CONDITION AFFECTING FOETUS 10 0.0452
62 FIBROMYALGIA 1001 0.0411
63 SYSTEMIC LUPUS ERYTHEMATOSUS 1444 0.0406
64 OBESITY 627 0.0393
65 LIVER INJURY 883 0.0359
66 PRODUCT LABEL CONFUSION 204 0.0350
67 LOWER RESPIRATORY TRACT INFECTION 1591 0.0349
68 OSTEOSCLEROSIS 55 0.0349
69 DRUG TOLERANCE DECREASED 98 0.0349
70 MATERNAL EXPOSURE TIMING UNSPECIFIED 130 0.0346
71 CONTRAINDICATED PRODUCT ADMINISTERED 1030 0.0340
72 INFUSION SITE REACTION 101 0.0338
73 BILIARY SEPSIS 15 0.0324
74 CAUSTIC INJURY 10 0.0321
75 LIFE EXPECTANCY SHORTENED 18 0.0317
76 COELIAC DISEASE 297 0.0302
77 BACK INJURY 327 0.0300
78 TYPE 2 DIABETES MELLITUS 990 0.0294
79 VERTEBRAL FORAMINAL STENOSIS 24 0.0291
80 DENTAL FISTULA 12 0.0288
81 ORAL CAVITY FISTULA 14 0.0286
82 BONE FRAGMENTATION 16 0.0286
83 BLISTER 1574 0.0280
84 CONGENITAL ANOMALY 216 0.0279
85 INTERVERTEBRAL DISC SPACE NARROWING 22 0.0273
86 STOMATITIS 1642 0.0270
87 TOOTH DISCOLOURATION 79 0.0268
88 SCIATICA 425 0.0266
89 EXPOSED BONE IN JAW 57 0.0263
90 EXOSTOSIS 240 0.0263
91 LOWER LIMB FRACTURE 504 0.0262
92 ARTHROPATHY 1446 0.0260
93 AORTIC CALCIFICATION 15 0.0258
94 NORMAL NEWBORN 140 0.0257
95 LORDOSIS 9 0.0256
96 PUSTULAR PSORIASIS 88 0.0256
97 PULMONARY FIBROSIS 489 0.0255
98 NIGHT SWEATS 805 0.0250
99 WALKING AID USER 162 0.0245
100 GAIT INABILITY 821 0.0245
101 BREAST CANCER STAGE II 204 0.0245
102 PSORIATIC ARTHROPATHY 979 0.0241
103 ACTINOMYCOSIS 23 0.0240
104 TASTE DISORDER 475 0.0234
105 PRESCRIBED OVERDOSE 444 0.0229
106 THERAPEUTIC PRODUCT EFFECT DECREASED 1025 0.0229
107 LUPUS-LIKE SYNDROME 205 0.0226
108 HEPATIC ENZYME INCREASED 1517 0.0222
109 ULCER HAEMORRHAGE 147 0.0217
110 BONE SWELLING 21 0.0217
111 INFUSION RELATED REACTION 1424 0.0215
112 JOINT DISLOCATION 227 0.0215
113 BLOOD CHOLESTEROL INCREASED 961 0.0206
114 OSTEOLYSIS 42 0.0205
115 DISCOMFORT 1219 0.0200
116 EXCESSIVE GRANULATION TISSUE 16 0.0199
117 OSTEOARTHRITIS 832 0.0196
118 ILL-DEFINED DISORDER 1165 0.0192
119 PALMAR ERYTHEMA 22 0.0191
120 RED BLOOD CELL SEDIMENTATION RATE INCREASED 207 0.0187
121 PRESCRIBED UNDERDOSE 368 0.0184
122 INJURY 1275 0.0181
123 RASH VESICULAR 87 0.0180
124 HIP ARTHROPLASTY 274 0.0179
125 PERIODONTAL DISEASE 25 0.0178
126 DEATH NEONATAL 24 0.0172
127 LIVER FUNCTION TEST INCREASED 370 0.0172
128 MITRAL VALVE CALCIFICATION 11 0.0171
129 ADVERSE REACTION 223 0.0168
130 PLEURAL FIBROSIS 17 0.0167
131 HYPERTROPHY 9 0.0166
132 INFLAMMATION 852 0.0165
133 LEFT ATRIAL DILATATION 21 0.0165
134 SWELLING 1521 0.0162
135 EYE INJURY 49 0.0161
136 EPILEPSY 490 0.0160
137 GASTROINTESTINAL DISORDER 1412 0.0157
138 WHEEZING 934 0.0157
139 LUNG DISORDER 771 0.0157
140 FOOT DEFORMITY 174 0.0157
141 EUSTACHIAN TUBE DYSFUNCTION 9 0.0156
142 CULTURE POSITIVE 13 0.0156
143 BONE LESION 56 0.0155
144 ABSCESS JAW 16 0.0154
145 EXTRADURAL ABSCESS 12 0.0153
146 C-REACTIVE PROTEIN INCREASED 555 0.0152
147 MUSCLE SPASTICITY 186 0.0151
148 ATROPHIC VULVOVAGINITIS 11 0.0150
149 VASCULAR CALCIFICATION 16 0.0150
150 EAR PAIN 291 0.0150
151 JOINT SWELLING 1800 0.0149
152 CERUMEN IMPACTION 13 0.0142
153 HEPATIC CIRRHOSIS 263 0.0140
154 AORTIC ARTERIOSCLEROSIS 36 0.0140
155 GINGIVAL ERYTHEMA 12 0.0139
156 DRUG-INDUCED LIVER INJURY 435 0.0139
157 SINUSITIS 1415 0.0138
158 BACTERIAL DISEASE CARRIER 10 0.0137
159 KYPHOSIS 24 0.0136
160 SLEEP DISORDER 950 0.0134
161 MUSCULOSKELETAL PAIN 692 0.0132
162 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 225 0.0131
163 DRUG INTOLERANCE 1264 0.0131
164 LOOSE TOOTH 42 0.0130
165 JAW FRACTURE 28 0.0130
166 ROAD TRAFFIC ACCIDENT 536 0.0128
167 NAIL INFECTION 18 0.0126
168 HILAR LYMPHADENOPATHY 11 0.0125
169 MOBILITY DECREASED 891 0.0124
170 KNEE ARTHROPLASTY 261 0.0124
171 SPONDYLOLISTHESIS 21 0.0121
172 RHEUMATOID ARTHRITIS 1374 0.0121
173 HEPATITIS 308 0.0120
174 DELIRIUM 417 0.0120
175 CYSTITIS NONINFECTIVE 16 0.0119
176 PRODUCT CONTAMINATION MICROBIAL 14 0.0117
177 OEDEMA 637 0.0117
178 PREGNANCY 235 0.0117
179 SEBORRHOEIC KERATOSIS 17 0.0117
180 CLEFT LIP AND PALATE 13 0.0116
181 MATERNAL EXPOSURE DURING PREGNANCY 1037 0.0116
182 PERIODONTITIS 25 0.0115
183 LIVER DISORDER 510 0.0115
184 TOOTH EROSION 14 0.0114
185 SPONDYLITIS 41 0.0113
186 CONTUSION 1083 0.0112
187 BACTERIAL TEST POSITIVE 25 0.0112
188 MYOSITIS 98 0.0109
189 SOFT TISSUE DISORDER 12 0.0108
190 GENERAL PHYSICAL HEALTH DETERIORATION 1234 0.0107
191 PULPITIS DENTAL 10 0.0106
192 SPINAL OSTEOARTHRITIS 93 0.0106
193 DRY MOUTH 851 0.0105
194 INTENTIONAL PRODUCT USE ISSUE 916 0.0104
195 JOINT STIFFNESS 269 0.0102
196 GENERAL SYMPTOM 76 0.0101
197 RESPIRATORY DISORDER 303 0.0101
198 PERIPHERAL SWELLING 1555 0.0101
199 ESCHERICHIA TEST POSITIVE 12 0.0100
200 OSTEITIS 25 0.0099
201 INFECTION 1433 0.0099
202 GINGIVAL RECESSION 19 0.0099
203 ESSENTIAL HYPERTENSION 18 0.0098
204 METASTASES TO SPINE 33 0.0098
205 CONFUSIONAL STATE 1568 0.0097
206 ALLERGY TO CHEMICALS 12 0.0096
207 TONGUE DISCOLOURATION 42 0.0096
208 HYPERSENSITIVITY 1732 0.0093
209 ATELECTASIS 90 0.0093
210 HAEMOTHORAX 27 0.0093
211 MUSCULOSKELETAL STIFFNESS 805 0.0092
212 DISABILITY 181 0.0091
213 AORTIC DILATATION 10 0.0090
214 DRUG TOLERANCE 45 0.0089
215 BODY TEMPERATURE INCREASED 178 0.0087
216 SENSITIVITY OF TEETH 15 0.0087
217 LUMBAR SPINAL STENOSIS 25 0.0085
218 ASPARTATE AMINOTRANSFERASE ABNORMAL 13 0.0085
219 ABDOMINAL DISCOMFORT 1422 0.0085
220 OSTEONECROSIS OF JAW 209 0.0084
221 PURULENT DISCHARGE 35 0.0082
222 NASOPHARYNGITIS 1505 0.0082
223 BACK DISORDER 130 0.0080
224 THERAPY NON-RESPONDER 359 0.0080
225 HYPOAESTHESIA 1176 0.0078
226 ALOPECIA 1526 0.0078
227 CARDIAC VENTRICULAR THROMBOSIS 10 0.0077
228 TREATMENT FAILURE 640 0.0077
229 FUNGAEMIA 12 0.0076
230 GINGIVITIS 41 0.0076
231 PULMONARY VALVE INCOMPETENCE 11 0.0075
232 PATHOLOGICAL FRACTURE 38 0.0075
233 WEIGHT INCREASED 1669 0.0074
234 DYSPEPSIA 727 0.0074
235 OTITIS EXTERNA 9 0.0074
236 MIGRAINE 698 0.0073
237 URTICARIA 1203 0.0072
238 OSTEOMYELITIS 130 0.0072
239 FISTULA DISCHARGE 9 0.0071
240 SPINAL DEFORMITY 12 0.0071
241 CULTURE URINE POSITIVE 10 0.0071
242 JOINT DESTRUCTION 11 0.0071
243 EXPOSURE DURING PREGNANCY 437 0.0070
244 ACUTE SINUSITIS 12 0.0070
245 SPINAL FUSION SURGERY 28 0.0069
246 MEDICATION ERROR 383 0.0069
247 GASTROOESOPHAGEAL REFLUX DISEASE 551 0.0068
248 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 115 0.0068
249 EXCORIATION 17 0.0067
250 AMNESIA 433 0.0066
251 GINGIVAL SWELLING 29 0.0066
252 HYPOVOLAEMIA 38 0.0065
253 HEPATIC CYST 22 0.0065
254 EAR INFECTION 172 0.0065
255 RADICULOPATHY 17 0.0064
256 SUSPECTED OFF LABEL USE 29 0.0064
257 DIVERTICULUM INTESTINAL 28 0.0064
258 COMPRESSION FRACTURE 34 0.0063
259 PHYSICAL DISABILITY 28 0.0063
260 NECK PAIN 350 0.0063
261 TENOSYNOVITIS 17 0.0062
262 PROTEIN TOTAL INCREASED 16 0.0060
263 DEFORMITY 56 0.0060
264 WEIGHT FLUCTUATION 62 0.0059
265 INGROWING NAIL 14 0.0059
266 PLASMACYTOMA 11 0.0059
267 TOOTH ABSCESS 60 0.0059
268 MASTICATION DISORDER 18 0.0059
269 DENTAL CARIES 65 0.0059
270 INTERVERTEBRAL DISC DEGENERATION 54 0.0058
271 TRICUSPID VALVE INCOMPETENCE 46 0.0058
272 ACTINIC KERATOSIS 15 0.0058
273 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
274 OSTEOPOROSIS 235 0.0057
275 FREQUENT BOWEL MOVEMENTS 154 0.0057
276 HYPERTENSION 1207 0.0057
277 LEFT VENTRICULAR HYPERTROPHY 24 0.0056
278 BONE DISORDER 102 0.0056
279 DECREASED INTEREST 33 0.0056
280 ORAL DISORDER 41 0.0056
281 CHEMICAL BURN OF SKIN 14 0.0055
282 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
283 POSTOPERATIVE WOUND INFECTION 36 0.0053
284 CHRONIC SINUSITIS 20 0.0053
285 INTERVERTEBRAL DISCITIS 10 0.0053
286 COMPUTERISED TOMOGRAM ABNORMAL 12 0.0053
287 CUSHINGOID 17 0.0053
288 KERATITIS 16 0.0053
289 CERVICAL SPINAL STENOSIS 9 0.0052
290 DIVERTICULUM 37 0.0052
291 OSTEOPENIA 79 0.0052
292 ANGIOPATHY 29 0.0052
293 DEAFNESS NEUROSENSORY 17 0.0052
294 GINGIVAL PAIN 41 0.0051
295 RECTAL HAEMORRHAGE 219 0.0051
296 RENAL CYST 40 0.0050
297 METASTASES TO BONE 81 0.0049
298 JAW DISORDER 27 0.0049
299 MUSCULAR WEAKNESS 555 0.0049
300 SPINAL COLUMN STENOSIS 23 0.0049
301 LOBAR PNEUMONIA 9 0.0049
302 PARAESTHESIA 754 0.0048
303 HYPERPARATHYROIDISM SECONDARY 12 0.0048
304 MEMORY IMPAIRMENT 654 0.0048
305 DILATATION VENTRICULAR 10 0.0048
306 LUNG INFILTRATION 42 0.0048
307 ABDOMINAL PAIN UPPER 966 0.0047
308 GINGIVAL DISORDER 18 0.0047
309 EMPHYSEMA 47 0.0047
310 NASAL SEPTUM DEVIATION 9 0.0046
311 BREATH ODOUR 11 0.0045
312 ADVERSE EVENT 415 0.0045
313 TONGUE DISCOMFORT 19 0.0045
314 INSOMNIA 1190 0.0045
315 AORTIC VALVE INCOMPETENCE 19 0.0045
316 SCOLIOSIS 27 0.0044
317 HYPERKERATOSIS 24 0.0043
318 HAEMANGIOMA 10 0.0043
319 PROSTATOMEGALY 17 0.0043
320 ORAL DISCOMFORT 60 0.0043
321 DERMATITIS CONTACT 49 0.0043
322 ORAL PAIN 96 0.0043
323 HYPERLIPIDAEMIA 51 0.0043
324 NEUROGENIC BLADDER 9 0.0043
325 TOOTH INFECTION 56 0.0042
326 UPPER RESPIRATORY TRACT INFECTION 196 0.0042
327 PYREXIA 1463 0.0042
328 CARDIOMEGALY 52 0.0042
329 ASTHMA 475 0.0042
330 PAIN IN JAW 119 0.0042
331 ANHEDONIA 110 0.0042
332 RASH 1821 0.0042
333 MITRAL VALVE INCOMPETENCE 47 0.0041
334 TONGUE ULCERATION 14 0.0041
335 WOUND SECRETION 16 0.0041
336 CLOSTRIDIUM TEST POSITIVE 9 0.0041
337 CHEST PAIN 756 0.0041
338 DENTAL OPERATION 10 0.0041
339 FUNCTIONAL GASTROINTESTINAL DISORDER 14 0.0040
340 ARTHRALGIA 1679 0.0040
341 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 193 0.0040
342 TOOTH FRACTURE 44 0.0040
343 SECOND PRIMARY MALIGNANCY 33 0.0040
344 HEPATIC LESION 17 0.0039
345 ARTERIOSCLEROSIS CORONARY ARTERY 26 0.0039
346 SYNOVIAL CYST 18 0.0039
347 CONDITION AGGRAVATED 1182 0.0039
348 BREAST CANCER STAGE I 36 0.0039
349 PERIPHERAL VASCULAR DISORDER 20 0.0039
350 MUSCLE SPASMS 706 0.0038
351 ARTERIOSCLEROSIS 36 0.0038
352 PRURITUS 1456 0.0038
353 INCORRECT PRODUCT ADMINISTRATION DURATION 82 0.0038
354 RENAL FAILURE CHRONIC 29 0.0038
355 CEREBRAL ATROPHY 15 0.0038
356 OEDEMA PERIPHERAL 458 0.0038
357 TOOTHACHE 68 0.0038
358 CANDIDIASIS 15 0.0037
359 PRODUCT PACKAGING CONFUSION 9 0.0037
360 COLITIS ULCERATIVE 165 0.0037
361 DECUBITUS ULCER 30 0.0037
362 THYROID NEOPLASM 10 0.0036
363 ORAL INFECTION 14 0.0036
364 INJECTION SITE REACTION 246 0.0036
365 TOOTH LOSS 74 0.0036
366 DEPRESSION 812 0.0036
367 DECREASED APPETITE 812 0.0035
368 SKIN PAPILLOMA 14 0.0035
369 BACTERAEMIA 41 0.0035
370 TENDERNESS 36 0.0035
371 NEPHROGENIC ANAEMIA 16 0.0035
372 UNDERDOSE 252 0.0034
373 AORTIC STENOSIS 12 0.0034
374 MULTIPLE MYELOMA 16 0.0034
375 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 244 0.0034
376 ADVERSE DRUG REACTION 308 0.0034
377 WHITE BLOOD CELL COUNT INCREASED 129 0.0034
378 RHINOVIRUS INFECTION 13 0.0033
379 JOINT EFFUSION 23 0.0033
380 OTITIS MEDIA 11 0.0033
381 SHOCK HAEMORRHAGIC 27 0.0033
382 PRODUCT USE ISSUE 610 0.0032
383 BLEPHARITIS 13 0.0032
384 BONE CANCER 14 0.0032
385 LABORATORY TEST ABNORMAL 95 0.0032
386 LYMPHOEDEMA 22 0.0032
387 RHINITIS ALLERGIC 14 0.0031
388 THROMBOPHLEBITIS 11 0.0031
389 HYPERTONIC BLADDER 9 0.0031
390 GLOSSITIS 11 0.0031
391 SPINAL CORD COMPRESSION 12 0.0031
392 TOOTH EXTRACTION 38 0.0031
393 POOR PERIPHERAL CIRCULATION 13 0.0030
394 PNEUMONIA FUNGAL 12 0.0030
395 FLUID RETENTION 154 0.0030
396 ABDOMINAL DISTENSION 315 0.0030
397 TOOTH DISORDER 66 0.0030
398 PNEUMOTHORAX 47 0.0030
399 WOUND DEHISCENCE 10 0.0030
400 PAIN 1817 0.0030
401 SINUS TACHYCARDIA 42 0.0030
402 PULMONARY MASS 44 0.0030
403 DYSLIPIDAEMIA 15 0.0030
404 PNEUMONIA 949 0.0029
405 GOITRE 12 0.0029
406 DYSPNOEA 1658 0.0029
407 PRODUCT QUALITY ISSUE 396 0.0029
408 TONGUE OEDEMA 11 0.0029
409 PARANASAL SINUS HYPERSECRETION 11 0.0029
410 ASTHENIA 1081 0.0029
411 VASCULAR DEVICE INFECTION 13 0.0029
412 HIATUS HERNIA 37 0.0029
413 GINGIVAL BLEEDING 39 0.0029
414 PRODUCT USE IN UNAPPROVED INDICATION 706 0.0028
415 INTERVERTEBRAL DISC PROTRUSION 62 0.0028
416 HYPOALBUMINAEMIA 22 0.0028
417 ORTHOPNOEA 9 0.0028
418 PAIN IN EXTREMITY 828 0.0028
419 SPINAL COMPRESSION FRACTURE 23 0.0028
420 ARTHRITIS 213 0.0027
421 PERIPHERAL ISCHAEMIA 11 0.0027
422 FACIAL PAIN 24 0.0027
423 VOMITING 1259 0.0027
424 HYPERURICAEMIA 11 0.0027
425 METASTASES TO LYMPH NODES 18 0.0027
426 FATIGUE 2074 0.0027
427 DEVICE RELATED INFECTION 41 0.0027
428 HEPARIN-INDUCED THROMBOCYTOPENIA 13 0.0026
429 HAEMOGLOBIN INCREASED 12 0.0026
430 INGUINAL HERNIA 16 0.0026
431 DERMATITIS ACNEIFORM 16 0.0026
432 FEELING HOT 161 0.0026
433 HAEMORRHOIDS 51 0.0026
434 MOUTH ULCERATION 55 0.0026
435 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
436 ABDOMINAL PAIN 601 0.0026
437 LUNG NEOPLASM 11 0.0026
438 PANCREATITIS 136 0.0026
439 CARDIOPULMONARY FAILURE 10 0.0026
440 CARDIAC MURMUR 22 0.0025
441 VULVOVAGINAL MYCOTIC INFECTION 10 0.0025
442 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
443 GAIT DISTURBANCE 484 0.0025
444 AZOTAEMIA 10 0.0025
445 HYPOKALAEMIA 115 0.0025
446 HUMERUS FRACTURE 12 0.0025
447 ECCHYMOSIS 17 0.0025
448 RIB FRACTURE 51 0.0025
449 LARGE INTESTINE POLYP 17 0.0025
450 ANAPHYLACTIC REACTION 135 0.0024
451 HICCUPS 20 0.0024
452 DEFAECATION URGENCY 17 0.0024
453 ROTATOR CUFF SYNDROME 31 0.0024
454 FISTULA 27 0.0024
455 TENDONITIS 37 0.0024
456 FOETAL EXPOSURE DURING PREGNANCY 194 0.0024
457 UROSEPSIS 22 0.0024
458 NEUTROPENIC SEPSIS 17 0.0024
459 KLEBSIELLA INFECTION 12 0.0024
460 MUCOSAL INFLAMMATION 62 0.0024
461 TACHYCARDIA 210 0.0024
462 FLANK PAIN 22 0.0023
463 ODYNOPHAGIA 14 0.0023
464 ENDOCARDITIS 12 0.0023
465 LACERATION 22 0.0023
466 SCAR 40 0.0023
467 ANXIETY 663 0.0023
468 BLOOD CALCIUM DECREASED 26 0.0023
469 PERIORBITAL OEDEMA 12 0.0023
470 HERPES SIMPLEX 15 0.0023
471 SUBCUTANEOUS ABSCESS 11 0.0023
472 LARYNGEAL OEDEMA 14 0.0023
473 MENINGITIS 15 0.0022
474 HEPATIC STEATOSIS 41 0.0022
475 FACE OEDEMA 37 0.0022
476 HIDRADENITIS 20 0.0022
477 ABDOMINAL HERNIA 10 0.0022
478 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
479 BRONCHITIS 161 0.0022
480 PLEURAL EFFUSION 132 0.0022
481 HYPOPHAGIA 55 0.0021
482 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
483 SKIN ABRASION 10 0.0021
484 ABSCESS LIMB 9 0.0021
485 ECONOMIC PROBLEM 32 0.0021
486 MALAISE 920 0.0021
487 POLYARTHRITIS 11 0.0021
488 HYPOMAGNESAEMIA 29 0.0021
489 DIARRHOEA 1343 0.0021
490 HYPOXIA 73 0.0021
491 WEIGHT DECREASED 578 0.0021
492 VISUAL IMPAIRMENT 256 0.0021
493 BONE LOSS 31 0.0021
494 HEPATOMEGALY 20 0.0020
495 RESPIRATORY RATE INCREASED 18 0.0020
496 FEELING DRUNK 15 0.0020
497 PROTHROMBIN TIME PROLONGED 12 0.0020
498 CELLULITIS 101 0.0020
499 MUSCULOSKELETAL CHEST PAIN 31 0.0020
500 THROMBOCYTOPENIA 223 0.0020
501 SEASONAL ALLERGY 28 0.0020
502 ANAPHYLACTIC SHOCK 51 0.0020
503 HEADACHE 1231 0.0020
504 DIZZINESS 979 0.0020
505 ISCHAEMIA 9 0.0020
506 FEMORAL NECK FRACTURE 10 0.0019
507 STAPHYLOCOCCAL INFECTION 64 0.0019
508 LEUKOCYTOSIS 35 0.0019
509 MASS 27 0.0019
510 CARDIAC VALVE DISEASE 11 0.0019
511 ADRENAL INSUFFICIENCY 23 0.0019
512 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
513 IMMUNODEFICIENCY 28 0.0019
514 MALNUTRITION 21 0.0019
515 HYPERTRANSAMINASAEMIA 13 0.0019
516 HYPERCALCAEMIA 23 0.0019
517 BLOOD MAGNESIUM DECREASED 16 0.0019
518 APPLICATION SITE REACTION 13 0.0018
519 PAPULE 13 0.0018
520 NODULE 24 0.0018
521 GROIN PAIN 16 0.0018
522 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
523 OFF LABEL USE 1586 0.0018
524 HYPERNATRAEMIA 9 0.0018
525 AGEUSIA 45 0.0018
526 NECROSIS 10 0.0018
527 HYPOAESTHESIA ORAL 27 0.0018
528 NEUROPATHY PERIPHERAL 170 0.0018
529 SINUS BRADYCARDIA 17 0.0018
530 CACHEXIA 9 0.0017
531 ORAL CANDIDIASIS 23 0.0017
532 APPLICATION SITE RASH 24 0.0017
533 HYDRONEPHROSIS 13 0.0017
534 MULTI-ORGAN FAILURE 30 0.0017
535 MUSCLE STRAIN 15 0.0017
536 ACUTE MYELOID LEUKAEMIA 27 0.0017
537 NOCTURIA 21 0.0017
538 ACUTE RESPIRATORY FAILURE 33 0.0017
539 OSTEONECROSIS 56 0.0017
540 BACK PAIN 396 0.0017
541 RESPIRATORY DISTRESS 47 0.0017
542 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
543 PURPURA 15 0.0017
544 HAND FRACTURE 12 0.0017
545 ABSCESS 27 0.0017
546 HYPOCALCAEMIA 32 0.0017
547 VAGINAL DISCHARGE 17 0.0017
548 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
549 CHOLELITHIASIS 54 0.0016
550 ASTHENOPIA 9 0.0016
551 INTESTINAL ISCHAEMIA 9 0.0016
552 IRON DEFICIENCY ANAEMIA 15 0.0016
553 IMPAIRED GASTRIC EMPTYING 22 0.0016
554 RHINITIS 13 0.0016
555 EPISTAXIS 120 0.0016
556 CARDIOGENIC SHOCK 23 0.0016
557 CARPAL TUNNEL SYNDROME 22 0.0016
558 FEBRILE NEUTROPENIA 104 0.0016
559 SINUS DISORDER 31 0.0016
560 MOUTH SWELLING 9 0.0016
561 ASPIRATION 17 0.0016
562 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
563 ANGINA UNSTABLE 10 0.0015
564 PETECHIAE 16 0.0015
565 CYST 19 0.0015
566 DERMATITIS 32 0.0015
567 LIGAMENT SPRAIN 15 0.0015
568 HAEMATOCRIT DECREASED 30 0.0015
569 MENTAL STATUS CHANGES 42 0.0015
570 MYOPATHY 13 0.0015
571 UTERINE LEIOMYOMA 11 0.0015
572 COAGULOPATHY 25 0.0015
573 BREAST MASS 10 0.0015
574 CARDIOMYOPATHY 22 0.0015
575 HYPOPHOSPHATAEMIA 11 0.0015
576 ARTHROPOD BITE 11 0.0015
577 EJECTION FRACTION DECREASED 23 0.0015
578 SPINAL DISORDER 14 0.0015
579 SKIN ULCER 38 0.0015
580 SKIN LESION 40 0.0015
581 PARAESTHESIA ORAL 21 0.0015
582 ACUTE CORONARY SYNDROME 12 0.0014
583 AORTIC ANEURYSM 11 0.0014
584 FLUID OVERLOAD 21 0.0014
585 VITAMIN D DEFICIENCY 14 0.0014
586 PREMATURE BABY 43 0.0014
587 PERICARDIAL EFFUSION 33 0.0014
588 METASTASES TO LIVER 25 0.0014
589 RASH PRURITIC 77 0.0014
590 APHTHOUS ULCER 11 0.0014
591 SLEEP APNOEA SYNDROME 27 0.0014
592 PANCYTOPENIA 79 0.0014
593 SWOLLEN TONGUE 44 0.0014
594 PULMONARY OEDEMA 63 0.0014
595 PSORIASIS 183 0.0014
596 BACTERIAL INFECTION 26 0.0014
597 BLOOD ALBUMIN DECREASED 11 0.0014
598 METASTASES TO LUNG 16 0.0014
599 SQUAMOUS CELL CARCINOMA 13 0.0014
600 LEUKOPENIA 69 0.0014
601 ORTHOSTATIC HYPOTENSION 24 0.0014
602 RESPIRATORY FAILURE 100 0.0014
603 MAJOR DEPRESSION 10 0.0014
604 MOUTH HAEMORRHAGE 10 0.0014
605 HYPERBILIRUBINAEMIA 14 0.0014
606 HYPERGLYCAEMIA 49 0.0013
607 ENCEPHALOPATHY 33 0.0013
608 POST-TRAUMATIC STRESS DISORDER 9 0.0013
609 FALL 445 0.0013
610 SWELLING FACE 87 0.0013
611 SKIN FISSURES 26 0.0013
612 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
613 VITREOUS FLOATERS 13 0.0013
614 PREMATURE DELIVERY 21 0.0013
615 FOOT FRACTURE 25 0.0013
616 LOCAL SWELLING 23 0.0013
617 URINARY INCONTINENCE 39 0.0013
618 HOSPICE CARE 13 0.0013
619 ACIDOSIS 10 0.0013
620 BREAST CANCER METASTATIC 14 0.0013
621 GASTRITIS 34 0.0013
622 ELECTROLYTE IMBALANCE 15 0.0013
623 PELVIC FRACTURE 10 0.0013
624 DIARRHOEA HAEMORRHAGIC 12 0.0013
625 PSEUDOMONAS INFECTION 11 0.0013
626 SKIN REACTION 18 0.0013
627 NEURALGIA 31 0.0013
628 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
629 SEPSIS 142 0.0013
630 DYSPHAGIA 120 0.0013
631 ATAXIA 15 0.0013
632 MUSCLE TWITCHING 29 0.0013
633 HAEMATURIA 43 0.0013
634 ATRIAL FLUTTER 10 0.0013
635 GRAFT VERSUS HOST DISEASE 9 0.0013
636 HYPOTENSION 251 0.0012
637 PULMONARY HYPERTENSION 26 0.0012
638 CYTOKINE RELEASE SYNDROME 25 0.0012
639 LYMPHADENOPATHY 44 0.0012
640 NAUSEA 982 0.0012
641 HOSPITALISATION 189 0.0012
642 SKIN DISORDER 41 0.0012
643 DYSPNOEA EXERTIONAL 46 0.0012
644 POLYURIA 10 0.0012
645 THERAPEUTIC RESPONSE DECREASED 74 0.0012
646 PULMONARY CONGESTION 16 0.0012
647 PHARYNGITIS 15 0.0012
648 PHARYNGITIS STREPTOCOCCAL 13 0.0012
649 DYSURIA 44 0.0012
650 DERMATITIS ALLERGIC 15 0.0012
651 RESPIRATORY TRACT INFECTION 31 0.0012
652 SUBDURAL HAEMATOMA 17 0.0012
653 URINARY TRACT INFECTION 201 0.0012
654 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
655 LEUKAEMIA 11 0.0012
656 DRUG INEFFECTIVE 1533 0.0012
657 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
658 SKIN INFECTION 13 0.0012
659 CORONARY ARTERY DISEASE 35 0.0012
660 RENAL FAILURE ACUTE 49 0.0012
661 RECALLED PRODUCT ADMINISTERED 11 0.0012
662 GENERALISED OEDEMA 14 0.0011
663 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
664 DYSGEUSIA 84 0.0011
665 HYPOTHYROIDISM 36 0.0011
666 ORAL HERPES 22 0.0011
667 SEPTIC SHOCK 49 0.0011
668 DEEP VEIN THROMBOSIS 73 0.0011
669 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
670 BRONCHOSPASM 16 0.0011
671 EMOTIONAL DISTRESS 135 0.0011
672 DEAFNESS 29 0.0011
673 MYELODYSPLASTIC SYNDROME 16 0.0011
674 MUSCLE ATROPHY 14 0.0011
675 PROTEINURIA 21 0.0011
676 OVARIAN CYST 11 0.0011
677 SPINAL FRACTURE 22 0.0011
678 GASTROENTERITIS 16 0.0011
679 ANAEMIA 209 0.0011
680 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
681 BASAL CELL CARCINOMA 17 0.0011
682 PNEUMONIA BACTERIAL 10 0.0011
683 LIP SWELLING 36 0.0011
684 CONJUNCTIVITIS 20 0.0011
685 ULCER 17 0.0011
686 HAEMATEMESIS 27 0.0011
687 GOUT 19 0.0011
688 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
689 MICTURITION URGENCY 12 0.0010
690 RED BLOOD CELL COUNT DECREASED 30 0.0010
691 QUALITY OF LIFE DECREASED 14 0.0010
692 IMPAIRED QUALITY OF LIFE 15 0.0010
693 POST PROCEDURAL COMPLICATION 20 0.0010
694 GLAUCOMA 20 0.0010
695 PRESYNCOPE 25 0.0010
696 SPLENOMEGALY 12 0.0010
697 CATARACT 61 0.0010
698 IMMUNOSUPPRESSION 9 0.0010
699 URINARY RETENTION 34 0.0010
700 BLOOD UREA INCREASED 17 0.0010
701 SKIN LACERATION 11 0.0010
702 BONE PAIN 59 0.0010
703 CANDIDA INFECTION 17 0.0010
704 HAEMORRHAGE INTRACRANIAL 15 0.0010
705 DEPRESSED MOOD 53 0.0010
706 RENAL FAILURE 133 0.0010
707 PNEUMONIA ASPIRATION 25 0.0010
708 LIMB INJURY 27 0.0010
709 END STAGE RENAL DISEASE 18 0.0010
710 NEPHROLITHIASIS 45 0.0010
711 OXYGEN SATURATION DECREASED 55 0.0010
712 SMALL INTESTINAL OBSTRUCTION 12 0.0010
713 CARDIAC FAILURE CONGESTIVE 78 0.0010
714 POOR VENOUS ACCESS 10 0.0010
715 NEUTROPENIA 131 0.0010
716 BLOOD BILIRUBIN INCREASED 26 0.0010
717 SINUS CONGESTION 13 0.0010
718 CHRONIC KIDNEY DISEASE 73 0.0010
719 PNEUMONITIS 26 0.0010
720 ASCITES 28 0.0010
721 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
722 RASH MACULO-PAPULAR 21 0.0009
723 HYPONATRAEMIA 53 0.0009
724 CIRCULATORY COLLAPSE 16 0.0009
725 POLLAKIURIA 39 0.0009
726 BONE DENSITY DECREASED 29 0.0009
727 ATRIAL FIBRILLATION 90 0.0009
728 CHOLECYSTITIS 11 0.0009
729 NEOPLASM PROGRESSION 32 0.0009
730 INFLAMMATORY BOWEL DISEASE 9 0.0009
731 POLYNEUROPATHY 11 0.0009
732 WRIST FRACTURE 11 0.0009
733 HEAD INJURY 29 0.0009
734 OESOPHAGITIS 10 0.0009
735 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
736 HYPERKALAEMIA 32 0.0009
737 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
738 NO THERAPEUTIC RESPONSE 11 0.0009
739 BLOOD SODIUM DECREASED 17 0.0009
740 HIP FRACTURE 29 0.0009
741 FUNGAL INFECTION 30 0.0009
742 NERVE INJURY 10 0.0009
743 COLITIS 34 0.0009
744 TREATMENT NONCOMPLIANCE 49 0.0009
745 GASTRIC ULCER 17 0.0009
746 LACRIMATION INCREASED 27 0.0009
747 EATING DISORDER 19 0.0009
748 EYELID PTOSIS 9 0.0009
749 MYOCARDIAL ISCHAEMIA 10 0.0009
750 SECRETION DISCHARGE 11 0.0009
751 PULMONARY EMBOLISM 82 0.0009
752 EYELID OEDEMA 10 0.0009
753 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
754 ACUTE KIDNEY INJURY 131 0.0009
755 BLOOD PRESSURE ABNORMAL 17 0.0009
756 CONSTIPATION 186 0.0009
757 UNRESPONSIVE TO STIMULI 22 0.0009
758 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
759 PHOTOPHOBIA 16 0.0008
760 PHARYNGEAL OEDEMA 13 0.0008
761 JOINT INJURY 18 0.0008
762 ERYTHEMA 171 0.0008
763 OROPHARYNGEAL PAIN 77 0.0008
764 HAEMOPTYSIS 23 0.0008
765 HERPES ZOSTER 47 0.0008
766 CYSTITIS 26 0.0008
767 EYE PAIN 46 0.0008
768 MUSCULOSKELETAL DISCOMFORT 14 0.0008
769 STEVENS-JOHNSON SYNDROME 18 0.0008
770 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
771 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
772 BLOOD POTASSIUM DECREASED 24 0.0008
773 PLASMA CELL MYELOMA 31 0.0008
774 SKIN CANCER 17 0.0008
775 CHOLECYSTECTOMY 9 0.0008
776 NEUTROPHIL COUNT DECREASED 32 0.0008
777 DRY EYE 39 0.0008
778 BLOOD CREATININE INCREASED 51 0.0008
779 UPPER LIMB FRACTURE 15 0.0008
780 APPLICATION SITE PRURITUS 17 0.0007
781 HAEMORRHAGE 78 0.0007
782 DEHYDRATION 99 0.0007
783 BONE MARROW FAILURE 15 0.0007
784 CYTOPENIA 9 0.0007
785 HAEMATOMA 19 0.0007
786 HEPATIC FAILURE 22 0.0007
787 SYNCOPE 73 0.0007
788 GALLBLADDER DISORDER 13 0.0007
789 MELAENA 16 0.0007
790 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
791 PLATELET COUNT DECREASED 77 0.0007
792 VIRAL INFECTION 24 0.0007
793 SKIN DISCOLOURATION 33 0.0007
794 COORDINATION ABNORMAL 10 0.0007
795 PELVIC PAIN 13 0.0007
796 RESTLESS LEGS SYNDROME 13 0.0007
797 LETHARGY 41 0.0007
798 LYMPHOMA 11 0.0007
799 DISEASE PROGRESSION 84 0.0007
800 HEMIPARESIS 12 0.0007
801 ECZEMA 37 0.0007
802 FLATULENCE 40 0.0007
803 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
804 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
805 HYPOKINESIA 10 0.0007
806 OVERDOSE 148 0.0007
807 EOSINOPHILIA 12 0.0007
808 IMMUNE SYSTEM DISORDER 9 0.0007
809 SKIN IRRITATION 31 0.0007
810 ARRHYTHMIA 32 0.0007
811 BURNING SENSATION 47 0.0007
812 FEAR 18 0.0007
813 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
814 VENTRICULAR TACHYCARDIA 11 0.0007
815 HEART RATE IRREGULAR 15 0.0007
816 ANGINA PECTORIS 19 0.0007
817 HAEMOGLOBIN DECREASED 68 0.0007
818 DIPLOPIA 17 0.0007
819 INTENTIONAL PRODUCT MISUSE 57 0.0007
820 BALANCE DISORDER 56 0.0006
821 THROMBOSIS 52 0.0006
822 BLOOD TEST ABNORMAL 9 0.0006
823 COUGH 179 0.0006
824 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
825 FRACTURE 12 0.0006
826 RASH PAPULAR 14 0.0006
827 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
828 ANOSMIA 9 0.0006
829 RETCHING 13 0.0006
830 PRODUCTIVE COUGH 29 0.0006
831 DERMATITIS ATOPIC 32 0.0006
832 PHOTOSENSITIVITY REACTION 10 0.0006
833 HOT FLUSH 45 0.0006
834 CONVULSION 34 0.0006
835 SKIN EXFOLIATION 50 0.0006
836 RASH ERYTHEMATOUS 28 0.0006
837 ERECTILE DYSFUNCTION 15 0.0006
838 HEPATOTOXICITY 13 0.0006
839 BLOOD PRESSURE FLUCTUATION 14 0.0006
840 CARDIAC ARREST 48 0.0006
841 FEMUR FRACTURE 18 0.0006
842 HYPOACUSIS 25 0.0006
843 BRAIN FOG 9 0.0006
844 RHINORRHOEA 37 0.0006
845 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
846 TINNITUS 26 0.0006
847 EYE SWELLING 21 0.0006
848 DRUG ERUPTION 10 0.0006
849 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
850 METABOLIC ACIDOSIS 18 0.0006
851 NASAL CONGESTION 33 0.0006
852 BLOOD PRESSURE DECREASED 37 0.0006
853 HYPOGLYCAEMIA 27 0.0006
854 EYE IRRITATION 32 0.0006
855 PALPITATIONS 65 0.0006
856 BLOOD POTASSIUM INCREASED 9 0.0006
857 SPEECH DISORDER 29 0.0006
858 DIABETES MELLITUS 42 0.0006
859 OCULAR HYPERAEMIA 26 0.0005
860 PRODUCT ADMINISTRATION ERROR 11 0.0005
861 VISUAL ACUITY REDUCED 18 0.0005
862 VERTIGO 33 0.0005
863 HEART RATE DECREASED 19 0.0005
864 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
865 LOCALISED INFECTION 13 0.0005
866 CHEST DISCOMFORT 55 0.0005
867 APHASIA 16 0.0005
868 BLOOD URINE PRESENT 10 0.0005
869 VISION BLURRED 72 0.0005
870 PAIN OF SKIN 14 0.0005
871 HALLUCINATION 39 0.0005
872 EYE DISORDER 17 0.0005
873 BLOOD PRESSURE INCREASED 79 0.0005
874 LOSS OF CONSCIOUSNESS 66 0.0005
875 IMPAIRED WORK ABILITY 11 0.0005
876 NEUROTOXICITY 9 0.0005
877 NERVOUS SYSTEM DISORDER 16 0.0005
878 MYALGIA 87 0.0005
879 HAEMATOCHEZIA 28 0.0005
880 DRUG RESISTANCE 13 0.0005
881 ACCIDENTAL EXPOSURE TO PRODUCT 52 0.0005
882 CHILLS 59 0.0005
883 APPLICATION SITE ERYTHEMA 13 0.0005
884 MENTAL IMPAIRMENT 12 0.0005
885 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
886 FEEDING DISORDER 10 0.0005
887 CARDIO-RESPIRATORY ARREST 20 0.0005
888 FEELING JITTERY 9 0.0005
889 RENAL DISORDER 22 0.0005
890 DRY SKIN 63 0.0005
891 RENAL INJURY 14 0.0005
892 DYSKINESIA 19 0.0005
893 INFLUENZA 52 0.0005
894 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
895 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
896 HYPERSOMNIA 13 0.0005
897 RENAL IMPAIRMENT 38 0.0005
898 ANGIOEDEMA 20 0.0005
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
900 CEREBRAL INFARCTION 11 0.0004
901 COGNITIVE DISORDER 21 0.0004
902 CEREBRAL HAEMORRHAGE 16 0.0004
903 THROAT IRRITATION 20 0.0004
904 ACUTE MYOCARDIAL INFARCTION 13 0.0004
905 SHOCK 10 0.0004
906 NEOPLASM MALIGNANT 29 0.0004
907 PROCEDURAL PAIN 12 0.0004
908 ILLNESS 44 0.0004
909 TARDIVE DYSKINESIA 12 0.0004
910 NO ADVERSE EVENT 77 0.0004
911 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
912 AGITATION 31 0.0004
913 TREMOR 70 0.0004
914 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 76 0.0004
915 GYNAECOMASTIA 13 0.0004
916 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
917 BRADYCARDIA 22 0.0004
918 MENTAL DISORDER 18 0.0004
919 LIVER FUNCTION TEST ABNORMAL 12 0.0004
920 DYSPHONIA 24 0.0004
921 UNEVALUABLE EVENT 31 0.0004
922 JAUNDICE 11 0.0004
923 DEATH 351 0.0004
924 THROAT TIGHTNESS 11 0.0004
925 PALLOR 11 0.0004
926 PANCREATITIS ACUTE 9 0.0004
927 INTESTINAL OBSTRUCTION 15 0.0004
928 HYPERHIDROSIS 50 0.0004
929 RASH GENERALISED 10 0.0004
930 PANIC ATTACK 14 0.0004
931 HEART RATE INCREASED 38 0.0004
932 GASTRIC DISORDER 13 0.0004
933 CARDIAC FAILURE 30 0.0004
934 SEIZURE 43 0.0004
935 IRRITABILITY 22 0.0004
936 ABASIA 9 0.0004
937 DIVERTICULITIS 10 0.0004
938 DEMENTIA 10 0.0004
939 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
940 RESTLESSNESS 13 0.0004
941 FLUSHING 36 0.0004
942 PRODUCT DOSE OMISSION ISSUE 104 0.0004
943 COVID-19 62 0.0004
944 PRODUCT DOSE OMISSION 23 0.0004
945 INTENTIONAL DOSE OMISSION 10 0.0004
946 DYSARTHRIA 13 0.0003
947 SURGERY 20 0.0003
948 INCORRECT ROUTE OF DRUG ADMINISTRATION 12 0.0003
949 SKIN BURNING SENSATION 24 0.0003
950 INTERSTITIAL LUNG DISEASE 16 0.0003
951 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
952 EYE PRURITUS 11 0.0003
953 CEREBROVASCULAR ACCIDENT 55 0.0003
954 BLINDNESS 13 0.0003
955 INFLUENZA LIKE ILLNESS 26 0.0003
956 RASH MACULAR 11 0.0003
957 DYSSTASIA 9 0.0003
958 ACCIDENTAL OVERDOSE 11 0.0003
959 AGGRESSION 15 0.0003
960 THERAPY INTERRUPTED 21 0.0003
961 THERAPY CESSATION 15 0.0003
962 LUNG NEOPLASM MALIGNANT 12 0.0003
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
964 BREAST CANCER 27 0.0003
965 FEELING ABNORMAL 69 0.0003
966 RHABDOMYOLYSIS 12 0.0003
967 DISORIENTATION 11 0.0003
968 SUICIDAL IDEATION 25 0.0003
969 SOMNOLENCE 54 0.0003
970 CARDIAC DISORDER 25 0.0003
971 TOXICITY TO VARIOUS AGENTS 42 0.0002
972 DRUG INTERACTION 39 0.0002
973 BLOOD GLUCOSE INCREASED 46 0.0002
974 HEPATIC FUNCTION ABNORMAL 9 0.0002
975 MYOCARDIAL INFARCTION 41 0.0002
976 COMA 11 0.0002
977 VAGINAL HAEMORRHAGE 10 0.0002
978 DEVICE DISLOCATION 10 0.0002
979 BLOOD GLUCOSE DECREASED 11 0.0002
980 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
981 NERVOUSNESS 11 0.0002
982 MULTIPLE SCLEROSIS 9 0.0002
983 DISTURBANCE IN ATTENTION 10 0.0002
984 SUICIDE ATTEMPT 11 0.0002
985 INJECTION SITE SWELLING 13 0.0002
986 INJECTION SITE PRURITUS 10 0.0001
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
988 ACNE 11 0.0001
989 INJECTION SITE PAIN 39 0.0001
990 PROSTATE CANCER 10 0.0001
991 DRUG DOSE OMISSION 18 0.0001
992 INJECTION SITE ERYTHEMA 13 0.0001
993 DEVICE ISSUE 9 0.0001
994 INCORRECT DOSE ADMINISTERED 15 0.0001